{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:21:50Z","timestamp":1774074110395,"version":"3.50.1"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1164\/rccm.201709-1797le","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T16:58:32Z","timestamp":1510765112000},"page":"967-968","source":"Crossref","is-referenced-by-count":0,"title":["The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"197","author":[{"given":"Christopher B.","family":"Cooper","sequence":"first","affiliation":[{"name":"University of California, Los Angeles, Los Angeles, California"},{"name":"GlaxoSmithKline, Brentford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Brusselle","sequence":"additional","affiliation":[{"name":"University of Ghent, Gent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Pascoe","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, King of Prussia, Pennsylvania, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[{"name":"University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,1]]},"reference":[{"key":"2026032023173967300_bib1","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/rccm.201701-0193OC","article-title":"Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment: data from the FLAME trial","volume":"195","author":"Roche","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023173967300_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/rccm.201705-0892LE","article-title":"What should be the cutoff value of blood eosinophilia as a predictor of inhaled corticosteroid responsiveness in patients with chronic obstructive pulmonary disease?","volume":"196","author":"Yilmaz","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023173967300_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1164\/rccm.201706-1105LE","article-title":"Reply: What should be the cutoff value of blood eosinophilia as a predictor of inhaled corticosteroid responsiveness in patients with chronic obstructive pulmonary disease?","volume":"196","author":"Roche","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023173967300_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023173967300_bib5","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N Engl J Med"},{"key":"2026032023173967300_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.rmed.2015.04.018","article-title":"Improvements in lung function with umeclidinium\/vilanterol versus fluticasone propionate\/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations","volume":"109","author":"Donohue","year":"2015","journal-title":"Respir Med"},{"key":"2026032023173967300_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.chest.2017.04.174","article-title":"Reduced COPD exacerbation risk correlates with improved FEV1: a meta-regression analysis","volume":"152","author":"Zider","year":"2017","journal-title":"Chest"},{"issue":"11","key":"2026032023173967300_bib8","first-page":"CD003794","article-title":"Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease","author":"Nannini","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032023173967300_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023173967300_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2026032023173967300_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S2213-2600(15)00091-0","article-title":"A new algorithm for the management of COPD","volume":"3","author":"Cooper","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/197\/7\/967\/67123063\/ajrccm_197_7_967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/197\/7\/967\/67123063\/ajrccm_197_7_967.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:17:44Z","timestamp":1774063064000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/197\/7\/967\/8498687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,4,1]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201709-1797le","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,4,1]]}}}